Intelligencia AI is proud to announce its inclusion on the 2026 Inc. 5000 list for the third consecutive year, ranking among America’s fastest-growing private companies. The company was also recognized within the Artificial Intelligence and Data industry, ranking No. 110.
This recognition reflects the growing impact of Intelligencia AI’s decision intelligence platform, helping pharmaceutical and biotech leaders make faster, more confident clinical development decisions through AI-driven predictions, benchmarking, and portfolio optimization.
The Inc. 5000 list represents a snapshot of the most successful companies within the American economy’s most dynamic segment, its independent, entrepreneurial businesses. Read more about this year’s list at inc.com/inc5000.
